有机催化
化学
对映选择合成
意义(存在)
药物发现
对映体
催化作用
纳米技术
组合化学
有机化学
哲学
材料科学
认识论
生物化学
作者
Leigh Krietsch Boerner
出处
期刊:C&EN global enterprise
[American Chemical Society]
日期:2021-10-11
卷期号:99 (37): 5-5
标识
DOI:10.1021/cen-09937-leadcon
摘要
The 2021 Nobel Prize in Chemistry has gone to Benjamin List of the Max Planck Institute for Kohlenforschung and David W. C. MacMillan of Princeton University for the discovery of asymmetric organocatalysis. This method uses small organic molecules as catalysts instead of traditional enzyme or metal catalysts. These molecules are able to catalyze reactions to selectively form one enantiomer of a particular compound—meaning one version of two possible mirror-image molecules. Asymmetric organocatalysis is a widely used technique and especially important to the drug discovery process. Biologically active molecules are often chiral, and organocatalysts provide a way to make candidate drug compounds quickly and efficiently. Using small organic molecules as catalysts is akin to mimicking enzymes , says David Nicewicz , an organocatalytic chemist at the University of North Carolina at Chapel Hill, who worked with MacMillan as a postdoctoral researcher over a decade ago. In this way, Nicewicz says, the
科研通智能强力驱动
Strongly Powered by AbleSci AI